Porous silicon microparticles for delivery of siRNA therapeutics

Journal of Visualized Experiments

Volumn , Issue 95, 2015, Pages

  Shen, Jianliang ^a,b   Wu, Xiaoyan ^a,c   Lee, Yeonju ^a   Wolfram, Joy ^a,d   Yang, Zhizhou ^a   Mao, Zong Wan ^b   Ferrari, Mauro ^a,e   Shen, Haifa ^a,e  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bioengineering; Cancer therapy; Issue 95; Nanodelivery system; Polycation functionalization; Porous silicon; SiRNA; Transfection

Indexed keywords

NANOCONJUGATE; POLYAMINE; POLYCATIONS; POLYETHYLENEIMINE; SILICON; SMALL INTERFERING RNA;

CHEMISTRY; GENETIC TRANSFECTION; GENETICS; HUMAN; MEMBRANE MICROPARTICLE; PROCEDURES; RNAI THERAPEUTICS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; HUMANS; NANOCONJUGATES; POLYAMINES; POLYETHYLENEIMINE; RNA, SMALL INTERFERING; RNAI THERAPEUTICS; SILICON; TRANSFECTION;

EID: 84921671480     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52075     Document Type: Article

References (17)

1. De Fougerolles, A., Vornlocher, H. P., Maraganore, J., Lieberman, J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 6, (6), 443-453 (2007).
2. Rolland, A. Gene medicines: the end of the beginning. Adv Drug Deliv Rev. 57, (5), 669-673 (2005).
3. Oh, Y. K., Park, T. G. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 61, (10), 850-862 (2009).
4. Mintzer, M. A., Simanek, E. E. Nonviral vectors for gene delivery. Chem Rev. 109, (2), 259-302 (2009).
5. Whitehead, K. A., Langer, R., Anderson, D. G. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 8, (2), 129-138 (2009).
6. Decuzzi, P., et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release. 141, (3), 320-327 (2010).
7. Decuzzi, P., Ferrari, M. Design maps for nanoparticles targeting the diseased microvasculature.Biomaterials. 29, (3), 377-384 (2008).
8. Martinez, J. O., Evangelopoulos, M., Chiappini, C., Liu, X., Ferrari, M., Tasciotti, E. Degradation and biocompatibility of multistage nanovectors in physiological systems. J Biomed Mater Res A. 102, (10), 3540-3549 (2014).
9. Shen, H., et al. Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Clin Cancer Res. 19, (7), 1806-1815 (2013).
10. Xu, R., et al. Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy.Small. 9, (9-10), 1799-1808 Forthcoming.
11. Shen, J., et al. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. ACS Nano. 7, (11), 9867-9880 (2013).
12. Zhang, M., et al. Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells. Biomaterials. 35, (1), 423-431 (2014).
13. Ozpolat, B., Sood, A. K., Lopez-Berestein, G. Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med. 267, (1), 44-53 (2010).
14. Philipp, A., Dehshahri, A., Wagner, A., E, Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem. 19, (7), 1448-1455 (2008).
15. Hunter, A. C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev. 58, (14), 1523-1531 (2006).
16. Andrews, P. M., Bates, S. B. Dose-dependent movement of cationic molecules across the glomerular wall.Anat Rec. 212, (3), 223-231 (1985).
17. Ananta, J. S., et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol. 5, (11), 815-821 (2010).